Sensus Healthcare (SRTS) Net Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sensus Healthcare | 47.41 Mn | 29.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.48% |
| Dec 31, 2025 | -203.45% |
| Sep 30, 2025 | -25.86% |
| Jun 30, 2025 | 203.55% |
| Mar 31, 2025 | -494.42% |
| Dec 31, 2024 | -114.00% |
| Sep 30, 2024 | -15.16% |
| Jun 30, 2024 | 150.20% |
| Mar 31, 2024 | -416.42% |
| Dec 31, 2023 | 513.13% |
| Sep 30, 2023 | -39.13% |
| Jun 30, 2023 | 111.54% |
| Mar 31, 2023 | 48.74% |
| Dec 31, 2022 | -411.23% |
| Sep 30, 2022 | 343.76% |
| Jun 30, 2022 | -95.23% |
| Mar 31, 2022 | 1,078.15% |
| Dec 31, 2021 | -257.71% |
| Sep 30, 2021 | -23.52% |
| Jun 30, 2021 | 223.67% |
| Mar 31, 2021 | -2.87% |
| Dec 31, 2020 | 46.68% |
| Sep 30, 2020 | -136.22% |
| Jun 30, 2020 | 58.00% |
| Mar 31, 2020 | 234.63% |
| Dec 31, 2019 | 126.38% |
| Sep 30, 2019 | -187.39% |
| Jun 30, 2019 | 183.15% |
| Mar 31, 2019 | -34.40% |
| Dec 31, 2018 | -150.91% |
| Sep 30, 2018 | 705.74% |
| Jun 30, 2018 | -164.28% |
| Mar 31, 2018 | -117.52% |
| Dec 31, 2017 | 24.23% |
| Sep 30, 2017 | 118.06% |
| Jun 30, 2017 | 159.45% |